Radicle Women's Health DNS™: A Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Women's Health Outcomes
- Sponsor
- Radicle Science
- Study ID
- NCT07735247
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Fatigue
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Placebo Health Control Product — DIETARY_SUPPLEMENTParticipants will use their Placebo Health Control Product as directed for a period of 8 weeks
- Active Health Product — DIETARY_SUPPLEMENTParticipants will use their Active Health Product as directed for a period of 8 weeks
Study Details
Radicle Women's Health DNSTM: A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on fatigue and related women's health outcomes
Key Dates
- First listed
- Jul 29, 2026
- Start date
- Jul 14, 2026
- Status verified
- May 2026
- Primary completion
- Jul 14, 2027
- Completion
- Jul 14, 2027
Study Design
- Enrollment
- 550 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Health & Fatigue ProductHealth \& Fatigue Active Product
- Placebo Comparator: Health & Fatigue Placebo ControlHealth \& Fatigue Placebo Control Health Product
Primary Outcome Measure
Change in fatigue [ Time Frame: 9 weeks ]
Related Studies
- Behavioral and Neural Representations of Subjective Effort CostRecruiting · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Baltimore, Maryland
- Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKDPHASE2 · Recruiting · University of California, Davis · Sacramento, California
- Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. VeteransRecruiting · University of Illinois at Chicago · Chicago, Illinois
- Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced CancerPHASE2/PHASE3 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas